Navigation Links
FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
Date:5/26/2009

chest pain after taking ADCIRCA they should seek immediate medical attention. Patients with a known serious hypersensitivity to tadalafil (ADCIRCA or CIALIS) should not take ADCIRCA.

PDE5 inhibitors, including tadalafil, have mild systemic vasodilatory properties that may result in transient decreases in blood pressure. Before prescribing ADCIRCA, physicians should carefully consider whether their patients with underlying cardiovascular disease could be adversely affected by such effects. Pulmonary vasodilators may significantly worsen the cardiovascular status of patients with pulmonary veno-occlusive disease (PVOD) and administration of ADCIRCA to these patients is not recommended. Patients should discuss their medical condition and all medications with their physician before starting ADCIRCA.

The use of ADCIRCA with alpha blockers, blood pressure medications, and alcohol may cause a lowering of blood pressure. Use of ADCIRCA with potent CYP3A inhibitors, such as ketoconazole and itraconazole, should be avoided. For patients on ADCIRCA therapy that require treatment with ritonavir, dosage adjustments are required. Certain populations of PAH patients such as those with mild-to-moderate renal or hepatic impairment or those taking the drug ritonavir should use a dose of 20 mg daily when beginning therapy with ADCIRCA. Use of ADCIRCA with potent inducers of CYP3A, such as rifampin, should be avoided. The safety and efficacy of combinations of ADCIRCA with CIALIS or other PDE5 inhibitors have not been studied. Therefore, the use of such combinations is not recommended.

The most common side effects with ADCIRCA seen in the PHIRST-1 clinical trial were headache, myalgia, nasopharyngitis, flushing, respiratory tract infection, extremity pain, nausea, back pain, dyspepsia and nasal congestion.

In rare instances, patients taking PDE5 inhibitors (including tadalafil) reported a sudden decrease or
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
2. FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
3. FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation
4. FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
5. FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder
6. FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. F.D.A. Approves SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy
9. FDA Approves First Hepatitis B Viral Load Test
10. U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinsons Disease
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... May 27, 2015 OpportunityAnalyzer: Cushing,s Syndrome ... Summary GlobalData estimates that the 2013 sales ... approximately $179m across the 6MM covered in this ... their attention, time, and financial resources in the ... and development (R&D) strategies. One notable example is ...
(Date:5/27/2015)... , May 27, 2015 The prevalence of ... by accelerated aging of population and changes in consumption ... has been growing year after year, thereby promoting the ... cases in China totaled 454,505 ... the interventional cardiovascular device industry there was worth RMB20.12 ...
(Date:5/27/2015)... 2015 Research and Markets ( ... "Asia Pacific Open System MRI Market - Growth, ... to their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... market is the fastest growing market for Open ... which is replacing CT because of its higher ...
Breaking Medicine Technology:OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 2OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 3OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 4China Interventional Cardiovascular Device Industry Report, 2014-2017 2China Interventional Cardiovascular Device Industry Report, 2014-2017 3Asia Pacific Open System MRI Market Trends and Forecasts 2015-2019 2
... BIOD ) announced today that it will be presenting at the ... Conference, September 28, 2010 at 12:00 pm Eastern time at the ... access a link to the live webcast of the presentation from ... . Replays of the presentation will be available for 90 days. ...
... FRAMINGHAM, Mass. and SYDNEY, Sept. 23 HeartWare International, ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that CEO Doug Godshall is scheduled to ... Assist Device Day from 2:00-3:00 pm EDT on Wednesday, ...
Cached Medicine Technology:HeartWare to Present at Lazard Capital Markets Circulatory Assist Device Day 2
(Date:5/27/2015)... Calls Upon Individuals, Organizations and Communities to Serve Veterans in ... “Summer of Service” – seeks the help of citizens in ... number of individuals and organizations serving Veterans. , The ... the community to visit and explore opportunities to serve Veterans ... 3:00 p.m. in the auditorium. , “We have made progress ...
(Date:5/27/2015)... 27, 2015 Ticket Down is a reputable source ... Chicago Blackhawks are currently in the middle of their series against ... the series. If the Blackhawks can win tonight at home, ... on Saturday, May 30th at the Honda Center in Anaheim. ... record in the Western Conference as they won the Pacific Division ...
(Date:5/27/2015)... 2015 Khanna Vision Institute (KVI) announced the ... focussed on keratoconus eye disease . Keratoconus is commonly ... its onset in the teenage years. It worsens over the ... front clear part of the eye is defective. It becomes ... It results in poor vision which cannot even be corrected ...
(Date:5/27/2015)... York, New York (PRWEB) May 27, 2015 ... ) filed on behalf of individuals who ... complications related to the use of the antipsychotic ... tort litigation currently underway in Pennsylvania’s Philadelphia Court ... litigation is proceeding with its bellwether trial program, ...
(Date:5/27/2015)... May 27, 2015 In today's healthcare ... tighter, it can be challenging for doctors and hospitals ... edge treatments. , Austin-based HealthTronics, Inc. ... invasive, mobile medical therapies for clinically sophisticated applications. The ... the acquisition of Laser Ventures, Inc ., a ...
Breaking Medicine News(10 mins):Health News:VA Begins “Summer of Service” to Bolster Volunteer Assistance for Veterans 2Health News:VA Begins “Summer of Service” to Bolster Volunteer Assistance for Veterans 3Health News:Blackhawks vs. Ducks NHL Western Conference Finals Tickets: Ticket Down Slashes Ticket Prices on Chicago Blackhawks vs. Anaheim Ducks 2015 NHL Western Conference Finals 2Health News:KVI announced the launch of The Keratoconus website focused on age based keratoconus treatment . 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 3Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3
... National Science Foundation (NSF) has awarded $3 million to ... research program on stem cell bio-manufacturing. The program is ... production, in order to meet the anticipated demand for ... Graduate Education and Research Traineeship (IGERT) Program, which supports ...
... to own their failure. It,s time for us to change ... advance warning to the old, big spending, do nothing, me ... 2008 College Station, TXAugust 16, 2010Change and hope were ... new longitudinal study published in the September issue of ...
... which assesses donor characteristics impacting liver transplantation outcomes, does not ... as is suggested from large-scale, national data. Rather, ... contributor to poor graft survival in transplant patients, according to ... study were to confirm the effect of the Donor Risk ...
... , ATLANTA Adults who have Internet access at ... than adults without Internet access, according to research to be ... Association. "Although prior research on the social impacts of ... of time spent online, our research suggests that Internet access ...
... have started to decline and level off for many ... ethnic minorities, according to a new UCSF-led study. ... underscores the need for more tailored intervention programs and ... The study, which is the first to find significant ...
... in which adolescent sexual activity occurs can substantially ... education, according to research to be presented at ... Association. "Compared to abstinence, sexual intercourse in ... in other types of relationships it is more ...
Cached Medicine News:Health News:NSF awards stem cell bio-manufacturing research and education program to Georgia Tech 2Health News:NSF awards stem cell bio-manufacturing research and education program to Georgia Tech 3Health News:Presidential election outcomes directly influence suicide rates 2Health News:Henry Ford Hospital study: Donor Risk Index does not impact outcomes on a small scale 2Health News:Internet access at home increases the likelihood that adults will be in relationships 2Health News:Obesity rates decline for many adolescents but disparities worsen 2Health News:Obesity rates decline for many adolescents but disparities worsen 3Health News:Sex between adolescents in romantic relationships is often harmless to their academics 2
... The Pop-On® all silicone self-adhesive male external ... of men. The unique 1.5-inch sheath with a ... a short or retracted penis. It may also ... desired or when users may benefit from a ...
... clear, all-silicone Foley catheters eliminate patient ... Foley catheter designs. As an inert, ... creating a safe, dependable Foley catheter. ... all-silicone catheters will not leach chemicals ...
Used for pediatric urethral dilation. The dilators have a closed, rounded, 20 angled tip. Supplied sterile in peel-open packages. Intended for one-time use....
... Used for stone manipulation and removal in ... the basket to retain its shape following extreme ... stone capture by allowing the basket to open ... the stone. The tipless design reduces the likelihood ...
Medicine Products: